Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Login to our social questions & Answers Engine to ask questions answer people’s questions & connect with other people.
Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Who truly owns health data—patients, hospitals, or tech companies?
Who Actually Owns Your Health Data? Spoiler: It’s Complicated Every time you see your doctor, get a blood draw, or even just strap on your Fitbit, you’re tossing more health data out into the universe. You’d think, “Hey, it’s my body, so that’s my data, right?” Ha. Not so fast. Your hospital’s got aRead more
Who Actually Owns Your Health Data? Spoiler: It’s Complicated
Every time you see your doctor, get a blood draw, or even just strap on your Fitbit, you’re tossing more health data out into the universe. You’d think, “Hey, it’s my body, so that’s my data, right?” Ha. Not so fast. Your hospital’s got a stash of your records, labs have their own pile, and Apple or Google probably knows more about your heart rate than your cardiologist does. It’s like a tug-of-war over who really gets to call your info theirs.
Gatekeepers in White Coats
For ages, hospitals have acted like the bouncers of your medical history. You wanted your records? Good luck—maybe they’ll fax you a copy if you beg (and pay). Now, with electronic health records, sharing is technically possible, but let’s be real: the hospital still guards the vault. You’re often left feeling like a peasant asking the king for access to your own castle.
Tech Bros and Data Hoarding
Then you’ve got the tech companies. They’re quietly sitting on Everest-sized mounds of your personal stuff—steps, sleep, DNA, you name it. Most of the time, you don’t even realize how much you’ve handed over. And they’re cashing in on it, too—selling “insights” or training their AI, all based on your biometrics. Is it still your data if it’s being chopped up and sold to the highest bidder? Who knows.
The Patient: Alleged Owner, Actual Bystander
You’d think patients would be the boss here. After all, it’s literally your blood, sweat, and tears (sometimes all three). But, honestly, most people can barely get a full copy of their own health record, let alone control who sees it or uses it. “Ownership” is a cool idea, but it’s mostly just a buzzword right now. In practice, patients are sitting on the bench while everyone else plays ball.
Why Should You Even Care?
Because it’s not just about paperwork. If hospitals lock up your files, switching doctors becomes a nightmare. If someone leaks your private info, your dignity (and maybe your job) is on the line. And hey, sharing health data can lead to wild breakthroughs—AI that finds cancer earlier, new treatments—but if nobody asks your permission, it’s just another way to get screwed.
The Models: Pick Your Poison
– Old School (hospital-based): Hospitals hold the cards, and you need their blessing for access.
– Tech Takeover: Apps and gadgets hoard your data, usually without much oversight.
– Patient First (the dream): You get the keys—view, share, delete your records. Some countries are actually trying this, believe it or not.
A Better Way: Stewardship, Not Ownership
Maybe it’s not about “owning” your data, but about who you trust to watch over it. You should be in the driver’s seat, deciding who gets a peek and why. Hospitals ought to keep it safe; tech companies should stop being so shady and actually ask before using your stuff. “My body, my data”—sure, but with some grownups making sure it doesn’t get lost, stolen, or misused.
Bottom Line
Right now, hospitals and tech giants are running the show, but the only real owner of your health info should be you. The trick is building systems where you get easy access, know exactly what’s happening with your data, and can actually say “nope” to anything you don’t like. Otherwise? It’s just business as usual… and you’re still on the outside looking in.
See lessCan AI-powered diagnostics outperform doctors, or should they only act as support tools?
The Wild, Weird Future of AI in Medicine Alright, let’s cut to the chase—AI’s been storming into medicine like it owns the place lately. These code-wizards? They chew through scans and spit out stuff even the sharpest docs would miss. Tumors, oddball patterns, “hey, your heart’s acting up”—all thatRead more
The Wild, Weird Future of AI in Medicine
Alright, let’s cut to the chase—AI’s been storming into medicine like it owns the place lately. These code-wizards? They chew through scans and spit out stuff even the sharpest docs would miss. Tumors, oddball patterns, “hey, your heart’s acting up”—all that jazz. It’s wild. Seriously, no human’s chugging through data at this pace. For patients, it’s a complete level-up: fewer twiddling-your-thumbs-in-waiting-rooms, answers before you even knew you had a question, the whole shebang.
Doctors vs. Robots: Not the Showdown You Think
Here’s the thing, though. Just because a computer can detect a lump in a nanosecond, that does not mean you’re going to be getting your next diagnosis from a talking toaster. Docs possess that sixth sense—you know, intuition, gut instincts, the things you can’t program. AI says “hey, this blob is weird,” but your doc puts the pieces together: your cough, your past traumas, the breakdown about your cat last Tuesday. It has nothing to do with being the robot who’s always right; it has everything to do with being the human being who understands.
Where AI Absolutely Crushes
Scanning pictures, day in and day out—radiology, pathology, whatever. AI never gets distracted or misses a pixel.
Acting as alarm system—cancer, diabetes, eye disease, name it. Sometimes before you even feel off at all.
Repetitive, dull tasks—AI thrive on the stuff that makes people want to scream.
It’s not that the robots are so smart, they just never get tired or have a hissy fit during shift time.
Where Humans Still Rule
– The dirty stuff—actual patients don’t read from the script, believe me.
– Delivering the bad news, soothing freak-outs, figuring out when to shut your mouth and listen. Luck with teaching an algorithm bedside manner.
– Ethics. Do we attack full bore with treatment, or is comfort care the way? AI regurgitates numbers, but human beings understand what counts.
Dream Team, Not Mortal Enemies
Seriously, it’s not a war. AI is not going to swipe your doctor’s white coat—it’s the world’s most compulsive intern, checking twice, flagging suspicious activity, but the doc’s still in charge. Team, baby. Fewer caught errors, less human mistake, better outcomes for you.
Don’t Bow Down to the Algorithm
But seriously, let’s not make AI some robot messiah. Bad data? The AI simply amplifies the screw-ups. Doctors questioning their own judgment? That’s a trainwreck. And when the tech fails—whose fault is it? Yeah, that becomes awkward.
Medicine Requires Actual Humans
Bottom line: AI’s not booting doctors out, it’s giving them superpowers (well, almost). People want a human talking to them, not just a screen spitting out diagnoses. But if a bot can spot something your doc missed? Use both, why not?
See lessWill telemedicine remain a permanent fixture in healthcare, or fade as in-person visits return?
The Pandemic As a Catalyst, Not a Trend There was no telemedicine prior to the pandemic, but overnight, COVID-19 turned it mainstream. What had previously been employed as a Plan B suddenly became the default mode of connection for millions with their doctors. From those with chronic illnesses intoRead more
The Pandemic As a Catalyst, Not a Trend
There was no telemedicine prior to the pandemic, but overnight, COVID-19 turned it mainstream. What had previously been employed as a Plan B suddenly became the default mode of connection for millions with their doctors. From those with chronic illnesses into their elder years to anxious parents wanting a speedy pediatrician’s opinion, individuals found the ease of in-home medical care. Now the question is whether telemedicine becomes part of the care fabric, or melts away as patients find themselves in waiting rooms again.
Convenience Accommodates Human Needs
The one benefit that has to be admitted is convenience. No hours of driving, no hours of sitting in a packed waiting room, no risk of getting sick. For people with mobility issues, for people who live in the rural areas, or working individuals who cannot afford to lose half a day of work, telemedicine is a lifeline. It brings care close, and very close, to individuals where they are. For follow-ups, routine check-ups, filling prescriptions, and mental health counseling, most patients would actually prefer a video visit over an in-person one.
The Limits of the Digital Doctor
Regardless, medicine remains quite human. A screen will never substitute the comforting presence of a doctor, the nuanced body language observed in a face-to-face exam, or the intimacy of immediate touch. Telemedicine finds it difficult with touch-based conditions—examining lungs via a stethoscope, observing signs of edema, or performing lab work. There’s even the risk of misdiagnosis when physicians can’t observe those physical signs. Medicine still feels more “real” to many when it comes in person.
A Hybrid Future: Blending the Best of Two Worlds
The future is going to be hybrid. Picture this: initial visits, minor ailments, and follow-ups done online; while life-critical tests, surgery, and complicated diagnoses done in person. This segregation provides choice to patients without a compromise on quality. Clinics and hospitals are already testing this “digital-physical” mix, where telemedicine is the first contact, lightening the burden on emergency departments and allowing doctors to only handle the serious ones.
Telemedicine Obstacles That Will Bring It to a Halt
The Human Touch: Why It Won’t Disappear
Telemedicine is not going away because it’s already redefine expectations. Once patients get used to the ease of a click of a button to get care, they don’t necessarily want to go back to the good old days on a regular basis. It’s not the new normal for care, maybe, but it’s become the adjunct, long-term piece of care. Healthcare is getting more patient-focused, and telemedicine is part of the whole deal.
In short: Telemedicine serves to stay, but not as replacement, but as indispensable addition to customary care. The stethoscope shall never be replaced by the webcam, but the webcam has won its place at the doctor’s desk.
See lessAre “green tariffs” (taxing carbon-heavy imports) the future of climate policy?
The new climate frontier Climate policy has always been about domestic action: clean energy subsidies, carbon prices, emissions controls and regulations. But there's increasing worry: what if a country covers its own industry by making it cleaner, then cheaper, dirtier imports come flooding in fromRead more
The new climate frontier
Climate policy has always been about domestic action: clean energy subsidies, carbon prices, emissions controls and regulations. But there’s increasing worry: what if a country covers its own industry by making it cleaner, then cheaper, dirtier imports come flooding in from abroad?
That’s carbon leakage — when tight climate regulations at home simply shift emissions elsewhere. Enter in the idea of green tariffs, or carbon border adjustment mechanisms (CBAMs). These are essentially tariffs on heavy-carbon foreign goods (like steel, cement, or fertilizer), to implement those and make the playing field fairer for cleaner domestic producers and foreign manufacturers that don’t have comparable climate rules.
Why green tariffs are gaining traction
1. Fairness to domestic industries
If you have one steel factory in Europe that spends a lot of money on costly clean tech and your competitor based overseas does not, the home factory is open to being undercut. Green tariffs are really saying: “If you want to sell here, you’ll have to play by similar climate rules.”
2. Climate integrity
Without border adjustments, benefits of domestic country climate can be offset by imported emissions. Green tariffs ensure reducing carbon at home doesn’t just ship pollution abroad.
3. Political sellability
Climate policy hurts workers and industries. Framing tariffs as saving local jobs from soiled imports makes climate policy politically sellable.
4. Pressure on other countries
By taxing carbon-intensive imports, wealthy nations can incentivize other nations’ exporters to green their supply chains. In theory, this supports climate standards around the globe.
The risks and controversies
1. Protectionism in disguise?
Green tariffs worry that they will be a new disguise for protectionism — hiding behind the language of climate to shield domestic industry. This will indulge WTO grievances and retaliation by trading partners.
2. Damage to developing countries
Poor nations can export high-carbon products because they cannot afford green technology. Green tariffs can be used to sanction them for poverty, inducing inequality at the global level unless in tandem with aid and technology transfer.
3. Price effect on consumers
As with other tariffs, the cost is passed on. Steel, cement, aluminum — these are the materials of which homes, automobiles, and highways are made. Green tariffs could mean higher cost to customers and taxpayers footing the bill for public infrastructure.
4. Measuring carbon’s complexity
How precisely do you actually measure the true carbon footprint of a product? A ton of Chinese coal-based steel is very different from Swedish renewable-energy-based steel. Tracking, verifying, and auditing emissions on international supply chains is a colossal technical challenge.
Early action: Europe leads the way
Who gains, who loses?
Winners
Losers:
Bottom line
Yes — green tariffs are becoming one of the strongest next-wave instruments of climate policy. They vow fairness, integrity, and global pressure to get carbon-cutting done. They also threaten protectionism, inequity, and more expensive consumer goods.
Short: green tariffs can help bend world trade into a lower-carbon path — if they are designed and sold as climate initiatives first, and as trade initiatives second.
See lessDo digital tariffs on cross-border data flows represent the next wave of trade barriers?
The promise: why tariffs are sold as job savers Tariffs have long been justified as a way to shield home workers from unfair foreign competition. The logic runs as follows: Low-cost imports flood the market and local factories shut. By placing tariffs on such imports, governments raise them in priceRead more
The promise: why tariffs are sold as job savers
The reality: varied job outcomes
1. Temporary job protection
Tariffs can slow down layoffs in specific industries (steel, textiles, or ag). Workers in those sectors do typically see temporary job protection.
As an example, American steel tariffs in the 2000s did protect some steel jobs in the short run.
2. But jobs relocate, not just save
When tariffs raise the price of imports, industries that use the imports as inputs are negatively affected. Automakers or construction firms that rely on steel are more costly to make.
That can lead to employment decreases in downstream industries — typically of greater size than jobs saved. A classic analysis of American steel tariffs found that greater numbers of jobs were lost in steel-using industries than jobs saved in steel production.
3. Long-term competitiveness
If tariffs become permanent, domestic businesses lose the incentive to innovate or become modernized. That can lock in inefficiency and end up costing jobs anyway, as the international market continues to move forward.
The hidden sticker shock: shoppers cover the cost
The paradox
The bigger picture: security vs. efficiency
Human impact — who gains, who loses?
Losers:
Bottom line
Tariffs generate some jobs at home, but they tend to do so at a collective expense to consumers and the economy in general. They’re akin to putting a bandage on one part of the economy while quietly sapping the strength of the rest of the body.
If the intention is actually to protect workers, tariffs alone are not enough. They would need to be followed by retraining programs, innovation policy, and competitiveness investment — or otherwise, they are expensive band-aids that shift suffering around rather than curing it.
See less